In subsequent cell functional experiments, the downregulation of PAX5 inhibited the proliferation (Fig. 7A), migration, and invasion (Fig. 7B) of ccRCC cells and promoted apoptosis (Fig. 7C), with the use of siRNA targeting PAX5. The gene discussed is PAX5; the disease is nonpapillary renal cell carcinoma.